ethyl 2,3-dihydropyrazolo[5,1-b][1,3]oxazole-6-carboxylate, 250mg

Potassium nitrate, min. 99%, pa, ISO, 500 g, plastic packaging.

4-(2-Morpholinoethyl)aniline, 95.0%, 1g

5-Bromo-1-methylpyridin-2(1H)-one, 95.0%, 10g

2,2,2-Trifluoro-N-(prop-2-yn-1-yl)acetamide, 95.0%, 25g

1-(4-Hexylphenyl)ethanone, 95.0%, 1g

5-((5-Nitrothiazol-2-yl)thio)-1,3,4-thiadiazol-2-amine, 98% HPLC, 250mg

3-Aminocyclohexanecarboxylic Acid (cis- and trans- mixture)>95.0%(T)5g

methyl 2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-1,3-benzodiazole-4-carboxylate, 95%, 250mg

5-Cyclopropyl-2-fluoro-3-iodopyridine, 97%, 500mg

4'-Isopropylacetophenone>95.0%(GC)25mL

Phenylhydrazine-4-sulfonamide, 95.0%, 5g

2,5-Dimethylphenylacetyl Chloride>98.0%(GC)(T)5g